Cigarette Smoking-Regulated PRKCE Is Involved in Bladder Cancer Susceptibility through cGMP/PKG-Dependent Glycolysis

Le résumé fourni par la source

High Resolution Image Download MS PowerPoint Slide The mechanism by which cigarette smoking affects bladder cancer susceptibility via glucose metabolism remains unclear. We identified bladder cancer-specific glucose metabolism-related genes (GMGs) using Molecular Signatures Database (MSigDB) and a case–control study (580 cases and 1,101 controls) through genetic association and interaction analyses with cigarette smoking. Among 811 GMGs, we observed that PRKCE rs4953292 G > A was significantly associated with increased bladder cancer risk [odds ratio (OR) = 1.19, 95% confidence interval (CI): 1.03–1.37, P adj = 1.87 × 10 –2 ] and exhibited an interaction effect with cigarette smoking ( P interaction < 0.05). Smokers with rs4953292 A allele had higher bladder cancer risk than nonsmokers with G allele ( P trend < 9.09 × 10 –3 ). We performed functional experiments using 4-aminobiphenyl (4-ABP)-treated bladder cancer cells and found that the rs4953292 A allele combined with 4-ABP decreased PRKCE expression levels in bladder cancer cells, which could upregulate PKG and phosphorylate VASP within the cGMP-PKG signaling pathway, enhance glucose uptake, lactate generation, and extracellular acidification rate (ECAR) to reprogram glycolysis, thus promoting bladder cancer susceptibility. This study elucidates that cigarette smoking-regulated PRKCE facilitates bladder cancer susceptibility by mediating glycolytic reprogramming through activating the cGMP-PKG signaling pathway. The findings provide valuable predictors for bladder cancer susceptibility, aiding in prevention strategies.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.